SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

NNVC nanoviricides, Inc: sufficient quantity of NV-387 oral gummies drug product for starting clinical trial against ebola is already availa

NNVC nanoviricides, Inc: sufficient quantity of NV-387 oral gummies drug product for starting clinical trial against ebola is already available in drc

NNVC

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.